MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Narrative)

Equity (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
Equity (Details Narrative) - USD ($)	Aug. 31, 2019	Jan. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Jul. 31, 2018
Preferred stock, shares authorized			50,000,000		50,000,000		50,000,000
Preferred stock,conversion amount						$ 34,044
Number of common stock issued during period					799,995
Share issued price			$ 3.25		$ 3.25
Total proceeds from issuance of common stock					$ 2,600,000	16,896,000
Number of shares issued during period, value					2,600,000	16,896,000
Loss on conversion				$ (2,407,671)		$ (4,184,631)
Exercise of options, shares						400,000
Number of warrants issued to purchase common stock				7,209,974		7,209,974		125,000
Stock issued in connection with the exercise of stock options, value					425,500	$ 39,000
Incentive Plan [Member]
Number of shares reserved	40,000,000
20M Debentures Holder [Member]
Promissory notes			7,500,000		7,500,000		$ 8,600,000
Accrued interest			$ 359,000		$ 359,000		62,000
Debt converted into common shares					3,591,523
Subscription outstanding, shares			3,206,816		3,206,816
20M Debentures [Member]
Number of common stock issued during period					3,206,816
Number of shares issued during period, value					$ 2,464,000
Harvest Foundation LLC [Member]
Number of common stock issued during period					1,000,000
Terrace Inc [Member]
Number of common stock issued during period					500,000
Third Parties [Member]
Shares in exchange for services						1,313,901
Loss on conversion						$ 959,000
Number of shares issued to retire promissory note, shares						1,679,486
Number of shares issued to retire promissory note						$ 1,175,000
Non cash loss on conversions						$ 918,000
Employees [Member]
Number of common stock issued during period	108,820
Share issued price	$ 1.78
Total proceeds from issuance of common stock	$ 194,000
Previously Issued Subscription [Member]
Number of common stock issued during period					97,136	1,000,000
Number of shares issued during period, value					$ 169,000	$ 370,000
Common Stock [Member]
Preferred stock,conversion shares						970,988
Preferred stock,conversion amount						$ 971
Number of common stock issued during period					799,995	14,189,738
Share issued price			$ 3.25		$ 3.25
Total proceeds from issuance of common stock					$ 2,600,000	$ 8,500,000
Number of shares issued during period, value					$ 800	$ 14,190
Exercise of options, shares					417,352	602,000
Stock issued in connection with the exercise of stock options, value					$ 417	$ 602
Common Stock [Member] \| Minimum [Member]
Share issued price				$ 0.50		$ 0.50
Common Stock [Member] \| Maximum [Member]
Share issued price				$ 1.30		$ 1.30
Stock Options [Member]
Number of common stock issued during period					417,352	602,000
Warrant [Member]
Number of warrants issued to purchase common stock			686,104	2,057,462	686,104	2,057,462
Series A convertible Preferred [Member]
Preferred stock, shares authorized		500,000
Preferred stock,conversion shares		970,988
Preferred stock, conversion price		$ 0.55
Preferred stock,conversion amount		$ 34,000
Common Stock Issuance Obligations [Member]
Promissory notes							$ 50,000
Subscription outstanding, shares							79,136
Exercise of options, shares					2,644,456	2,644,456
Stock issued in connection with the exercise of stock options, value					$ 414,000
Accrued interest							$ 1,454
Subscription outstanding, value							$ 95,000
Common Stock Issuance Obligations [Member] \| September 2018 through January 2019 [Member]
Subscription outstanding, shares							18,000
Subscription outstanding, value							$ 74,000
Common Stock Issuance Obligations [Member] \| Meditaurus LLC [Member] \| Fourth Quarter of 2019 [Member]
Number of common stock issued during period					752,260
Number of shares issued during period, value					$ 2,080,000